Studying lactate levels in patients with septic shock
Official title: Lactate Kinetics in Patients Treated for Septic Shock
Run by Karolinska University Hospital · NCT05349370 · Data updated 2026-11-12
This study is testing how lactate levels change in adults with septic shock in the ICU to see if it can help us understand their condition better and improve their care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Karolinska University Hospital Academic / other |
| Locations | 1 site (Stockholm, Stockholm County) |
| Status | Recruiting |
| Started | December 28, 2022 |
| Main results expected | March 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 23, 2025 |
| Trial ID | NCT05349370 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 17 years old who have been diagnosed with sepsis and have an arterial catheter in place.
✕Probably not a fit
Patients with mitochondrial defects, degenerative muscle diseases, or terminal liver failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates lactate kinetics in adult patients diagnosed with septic shock who are admitted to the Intensive Care Unit. Participants will receive a bolus injection of stable isotopically labeled lactate, followed by multiple blood samples taken over a two-hour period to analyze lactate production and consumption. The goal is to better understand the metabolic processes involved in sepsis and how lactate levels correlate with patient outcomes. The study aims to recruit patients within 72 hours of symptom onset to ensure timely data collection.
Why it matters
Potential benefit: If successful, this research could lead to improved management and treatment strategies for patients suffering from septic shock.
How similar studies have gone: While studies on lactate kinetics exist, this specific approach using isotopically labeled lactate in septic patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Sepsis * Age \>17 years * Arterial catheter * Lactate \> 2 mmol at any time point prior to inclusion Exclusion Criteria: * Mitochondrial defect * Degenerative muscle disease * Terminal liver failure
Where it's running
-
Karolinska University Hospital
Stockholm, Stockholm County, Sweden Recruiting
Study contacts
- Study coordinator: Jonathan Grip, MD, PhD
- Email: jonathan.grip@regionstockholm.se
- Phone: +46736230906
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
-
Personalized Fluid Resuscitation in the Emergency Department
This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.
-
Discordance between capillary refill time and oxygen use in septic shock
This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.
-
Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock
This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.
-
Cortisol Levels and Mortality in Septic Shock ICU Patients
This study tests whether cortisol levels can predict death or recovery in adults with sepsis or septic shock in the ICU.
-
oXiris hemofilter use for adults with septic shock and kidney failure
This study tests whether using the oXiris hemofilter during continuous dialysis helps adults with septic shock and acute kidney injury survive and stabilize faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.